Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,376 INR | +0.05% |
|
+3.25% | +26.91% |
Jun. 27 | Aurobindo Pharma Arm's Injectable Facility Gets 'Voluntary Action Indicated' Classification from US FDA | MT |
Jun. 24 | INDIA STOCKS-Financials weigh on Indian shares; small-, mid-caps fall | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.91% | 9.64B | |
+63.05% | 856B | |
+39.42% | 631B | |
-4.78% | 359B | |
+17.52% | 325B | |
+8.43% | 297B | |
+14.19% | 244B | |
+5.81% | 234B | |
+16.77% | 226B | |
+14.63% | 177B |
- Stock Market
- Equities
- AUROPHARMA Stock
- News Aurobindo Pharma
- Aurobindo Pharma Arm Gets US FDA Nod for Amphotericin B Liposome